System Guide
Back to Search Results

Search Results

Display Options
Display Options
Select Fields
Export Results to CSV Create Report 0
+ Add all results to report

Report Produced: 12/21/2025 04:04 AM

Report Question ID Question
20081028 Multiplicity Counter--Ill-defined sites: How is this field coded for Ill-Defined sites (C760-C768)?
20071096 Multiplicity Counter--Prostate: How is multiplicity counter to be coded for a clinically inapparent prostate cancer for which sextant needle biopsy cores on left and right sides are positive for adenocarcinoma? See Discussion.
20021040 Other Therapy: What code is used to represent treatment with "Epithilone" or "Epothilone"?
20000452 Other Therapy: What code is used to represent "gene" therapy? See discussion.
20031129 Primary Site: How is this field coded for cholangiocarcinoma involving the intrapancreatic bile duct?
20051022 Primary Site--Breast: Would a tumor described as located "lower central" be coded to C501 (central) or C508 overlapping (lower)?
20021078 Primary Site: How do you code the primary site when the tumor is identified in a bladder that was reconstructed using a stomach augmentation procedure and the pathology report states, "Bladder/prostate: adenocarcinoma arising within gastric mucosa, with the following features: highly infiltrative through the bladder wall"?
20021183 Primary Site--Head & Neck: What site code is used to represent the following head and neck primary where there is not a clear statement of primary site? See discussion.
20000851 Primary Site: What site code is used to classify a femur biopsy with pathologic diagnosis of "Ewing sarcoma/primitive neuroectodermal tumor (PNET)"? See discussion.
20000845 Primary Site: What code should be used to represent the site for an "extraovarian" papillary serous adenocarcinoma located in the "rectal muscle sheath"? See discussion.